Categories: News

Beyond Medical Technologies Inc. Announces Resignation of Dr. Hyder A. Khoja from Its Board of Directors

Vancouver, British Columbia–(Newsfile Corp. – August 12, 2024) – Beyond Medical Technologies Inc. (CSE: DOCT) (FSE: 7FM) (OTC Pink: DOCKF) (“Beyond Medical” or the “Company“) announced today the resignation of Independent Board Director, Dr. Hyder A. Khoja.

“We would like to thank Dr. Khoja for his service on the Board since 2017 and wish him well in his future endeavors,” expressed Kal Malhi, CEO of Beyond Medical Technologies Inc.

The Board will begin a search for a new Independent Director and will notify the market when a replacement has been interviewed and selected.

On behalf of the Board of Directors

“Kal Malhi”
Chief Executive Officer
Email: kal@bullruncapital.ca
https://beyond-md.ca/

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/219721

Staff

Recent Posts

Psyence Biomed Further Strengthens Scientific Advisory Board with Appointment of Dr. Dan J. Stein

Appointment adds significant clinical and scientific expertise in the field of psychedelic-based therapiesNew York, New…

3 hours ago

Celebrating a Decade of Care: Aeroflow Urology Marks 10 Years of Supporting Those Afflicted by Incontinence Across the U.S.A.

Aeroflow Urology's 97% customer satisfaction rating is a testament to the company’s commitment to personalized…

3 hours ago

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace

EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC)…

3 hours ago

Femasys Secures Distribution Partnerships for Commercialization of FemBloc® in Spain

-- Company taps first EU distributors, Comercial Medico Quirurigca, SA and Durgalab, as the first…

3 hours ago

Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI

SAN MATEO, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today…

3 hours ago